Natural experiments — MCQs

10 questions

A study is funded by the tobacco industry to examine the association between smoking and lung cancer. They design a study with a prospective cohort of 1,000 smokers between the ages of 20-30. The length of the study is five years. After the study period ends, they conclude that there is no relationship between smoking and lung cancer. Which of the following study features is the most likely reason for the failure of the study to note an association between tobacco use and cancer?

A pharmaceutical corporation has asked you to assist in the development of a randomized controlled trial (RCT) to evaluate the response of renal cell carcinoma to a novel chemotherapeutic agent. Despite all of the benefits that an RCT has to offer, which of the following would make an RCT unacceptable with regard to study design?

An investigator is measuring the blood calcium level in a sample of female cross country runners and a control group of sedentary females. If she would like to compare the means of the two groups, which statistical test should she use?

Which of the following study designs would be most appropriate to investigate the association between electronic cigarette use and the subsequent development of lung cancer?

A biostatistician is processing data for a large clinical trial she is working on. The study is analyzing the use of a novel pharmaceutical compound for the treatment of anorexia after chemotherapy with the outcome of interest being the change in weight while taking the drug. While most participants remained about the same weight or continued to lose weight while on chemotherapy, there were smaller groups of individuals who responded very positively to the orexic agent. As a result, the data had a strong positive skew. The biostatistician wishes to report the measures of central tendency for this project. Just by understanding the skew in the data, which of the following can be expected for this data set?

You submit a paper to a prestigious journal about the effects of coffee consumption on mesothelioma risk. The first reviewer lauds your clinical and scientific acumen, but expresses concern that your study does not have adequate statistical power. Statistical power refers to which of the following?

You are currently employed as a clinical researcher working on clinical trials of a new drug to be used for the treatment of Parkinson's disease. Currently, you have already determined the safe clinical dose of the drug in a healthy patient. You are in the phase of drug development where the drug is studied in patients with the target disease to determine its efficacy. Which of the following phases is this new drug currently in?

You are conducting a lab experiment on skeletal muscle tissue to examine force in different settings. The skeletal muscle tissue is hanging down from a hook. The experiment has 3 different phases. In the first phase, you compress the muscle tissue upwards, making it shorter. In the second phase, you attach a weight of 2.3 kg (5 lb) to its lower vertical end. In the third phase, you do not manipulate the muscle length at all. At the end of the study, you see that the tension is higher in the second phase than in the first one. What is the mechanism underlying this result?

A statistician wants to study the effects of a medicine in three groups-humans, animals, and plants. He then selects randomly from these three groups. Which type of sampling is being performed?

Q10

A study was undertaken to establish the relationship between the consumption of a vegetarian or non-vegetarian diet and the presence of diseases. Which statistical test should be used?

Natural experiments US Medical PG Practice Questions and MCQs

Question 1: A study is funded by the tobacco industry to examine the association between smoking and lung cancer. They design a study with a prospective cohort of 1,000 smokers between the ages of 20-30. The length of the study is five years. After the study period ends, they conclude that there is no relationship between smoking and lung cancer. Which of the following study features is the most likely reason for the failure of the study to note an association between tobacco use and cancer?

A. Late-look bias
B. Latency period (Correct Answer)
C. Confounding
D. Effect modification
E. Pygmalion effect

Explanation: ***Latency period*** - **Lung cancer** typically has a **long latency period**, often **20-30+ years**, between initial exposure to tobacco carcinogens and the development of clinically detectable disease. - A **five-year study duration** in young smokers (ages 20-30) is **far too short** to observe the development of lung cancer, which explains the false negative finding. - This represents a **fundamental flaw in study design** rather than a bias—the biological timeline of disease development was not adequately considered. *Late-look bias* - **Late-look bias** occurs when a study enrolls participants who have already survived the early high-risk period of a disease, leading to **underestimation of true mortality or incidence**. - Also called **survival bias**, it involves studying a population that has already been "selected" by survival. - This is not applicable here, as the study simply ended before sufficient time elapsed for disease to develop. *Confounding* - **Confounding** occurs when a third variable is associated with both the exposure and outcome, distorting the apparent relationship between them. - While confounding can affect study results, it would not completely eliminate the detection of a strong, well-established association like smoking and lung cancer in a properly conducted prospective cohort study. - The issue here is temporal (insufficient follow-up time), not the presence of an unmeasured confounder. *Effect modification* - **Effect modification** (also called interaction) occurs when the magnitude of an association between exposure and outcome differs across levels of a third variable. - This represents a **true biological phenomenon**, not a study design flaw or bias. - It would not explain the complete failure to detect any association. *Pygmalion effect* - The **Pygmalion effect** (observer-expectancy effect) refers to a psychological phenomenon where higher expectations lead to improved performance in the observed subjects. - This concept is relevant to **behavioral and educational research**, not to objective epidemiological studies of disease incidence. - It has no relevance to the biological relationship between carcinogen exposure and cancer development.

Question 2: A pharmaceutical corporation has asked you to assist in the development of a randomized controlled trial (RCT) to evaluate the response of renal cell carcinoma to a novel chemotherapeutic agent. Despite all of the benefits that an RCT has to offer, which of the following would make an RCT unacceptable with regard to study design?

A. Proper treatment response is very common
B. The treatment is not widespread in use
C. The treatment does not represent the best known option
D. The treatment is expensive
E. The treatment has a known, adverse outcome (Correct Answer)

Explanation: ***The treatment has a known, adverse outcome*** - If a treatment is already known to cause **significant harm** or an adverse outcome, it would be unethical to randomize patients to receive it, as this would expose them to unnecessary risk. - **Ethical considerations** are paramount in clinical trial design; exposing patients to a known harmful treatment violates the principle of non-maleficence. *Proper treatment response is very common* - A high treatment response rate would make it **easier to detect a difference** between the novel agent and a control group, potentially requiring a smaller sample size. - This scenario actually **facilitates** an RCT, as it increases the likelihood of demonstrating efficacy for the novel agent. *The treatment is not widespread in use* - The purpose of an RCT for a novel agent is precisely to evaluate its efficacy and safety to determine if it **deserves widespread use**. - Lack of widespread use is the **starting point** for clinical trials, not a contraindication. *The treatment does not represent the best known option* - An RCT is often conducted to determine if a novel treatment is **superior or non-inferior** to existing standard-of-care treatments, even if the existing options are not considered "the best." - Comparing a new treatment against a suboptimal current standard is a common and **valid objective** in clinical research to seek improvement. *The treatment is expensive* - The cost of a treatment is a **practical consideration** for healthcare systems and patients but does not inherently make an RCT unacceptable in terms of study design or ethics. - **Cost-effectiveness** is often evaluated after efficacy and safety are established, usually in addition to the RCT or in subsequent studies.

Question 3: An investigator is measuring the blood calcium level in a sample of female cross country runners and a control group of sedentary females. If she would like to compare the means of the two groups, which statistical test should she use?

A. Chi-square test
B. Linear regression
C. t-test (Correct Answer)
D. ANOVA (Analysis of Variance)
E. F-test

Explanation: ***t-test*** - A **t-test** is appropriate for comparing the means of two independent groups, such as the blood calcium levels between runners and sedentary females. - It assesses whether the observed difference between the two sample means is statistically significant or occurred by chance. *Chi-square test* - The **chi-square test** is used to analyze categorical data to determine if there is a significant association between two variables. - It is not suitable for comparing continuous variables like blood calcium levels. *Linear regression* - **Linear regression** is used to model the relationship between a dependent variable (outcome) and one or more independent variables (predictors). - It aims to predict the value of a variable based on the value of another, rather than comparing means between groups. *ANOVA (Analysis of Variance)* - **ANOVA** is used to compare the means of **three or more independent groups**. - Since there are only two groups being compared in this scenario, a t-test is more specific and appropriate. *F-test* - The **F-test** is primarily used to compare the variances of two populations or to assess the overall significance of a regression model. - While it is the basis for ANOVA, it is not the direct test for comparing the means of two groups.

Question 4: Which of the following study designs would be most appropriate to investigate the association between electronic cigarette use and the subsequent development of lung cancer?

A. Subjects with lung cancer who smoke and subjects with lung cancer who did not smoke
B. Subjects who smoke electronic cigarettes and subjects who smoke normal cigarettes
C. Subjects with lung cancer who smoke and subjects without lung cancer who smoke
D. Subjects with lung cancer and subjects without lung cancer
E. Subjects who smoke electronic cigarettes and subjects who do not smoke (Correct Answer)

Explanation: ***Subjects who smoke electronic cigarettes and subjects who do not smoke*** - This design represents a **cohort study**, which is ideal for investigating the **incidence** of a disease (lung cancer) in groups exposed and unexposed to a risk factor (electronic cigarette use). - By following these two groups over time, researchers can directly compare the **risk of developing lung cancer** in e-cigarette users versus non-smokers. *Subjects with lung cancer who smoke and subjects with lung cancer who did not smoke* - This option incorrectly compares two groups both with lung cancer, where the exposure to smoking can either be **electronic or traditional cigarettes,** but does not provide a control group without lung cancer to assess the association. - This design would not allow for the calculation of an **incidence rate** or a **relative risk** of lung cancer development specific to electronic cigarette use. *Subjects who smoke electronic cigarettes and subjects who smoke normal cigarettes* - This design compares two different types of smoking, which might be useful for comparing their relative risks but doesn't include a **non-smoking control group** to establish the absolute association with electronic cigarettes. - While it could show if e-cigarettes are "safer" than traditional cigarettes, it wouldn't directly answer whether e-cigarettes themselves **cause lung cancer**. *Subjects with lung cancer who smoke and subjects without lung cancer who smoke* - This describes a **case-control study** but focuses on smoking in general rather than specifically electronic cigarettes, which is the independent variable of interest. - While valuable for identifying risk factors, it would need to specifically differentiate between **electronic cigarette smokers** and other smokers to answer the question adequately. *Subjects with lung cancer and subjects without lung cancer* - This general description of a **case-control study** is too broad; it does not specify the exposure of interest, which is electronic cigarette use. - To be relevant, the study would need to gather data on **electronic cigarette use** in both the lung cancer group and the non-lung cancer control group.

Question 5: A biostatistician is processing data for a large clinical trial she is working on. The study is analyzing the use of a novel pharmaceutical compound for the treatment of anorexia after chemotherapy with the outcome of interest being the change in weight while taking the drug. While most participants remained about the same weight or continued to lose weight while on chemotherapy, there were smaller groups of individuals who responded very positively to the orexic agent. As a result, the data had a strong positive skew. The biostatistician wishes to report the measures of central tendency for this project. Just by understanding the skew in the data, which of the following can be expected for this data set?

A. Mean = median = mode
B. Mean < median < mode
C. Mean > median > mode (Correct Answer)
D. Mean > median = mode
E. Mean < median = mode

Explanation: ***Mean > median > mode*** - In a dataset with a **strong positive skew**, the tail of the distribution is on the right, pulled by a few **unusually large values**. - These extreme high values disproportionately influence the **mean**, pulling it to the right (higher value), while the **median** (middle value) is less affected, and the **mode** (most frequent value) is often located at the peak of the distribution towards the left. *Mean = median = mode* - This relationship between the measures of central tendency is characteristic of a **perfectly symmetrical distribution**, such as a **normal distribution**, where there is no skew. - In a symmetrical distribution, the mean, median, and mode are all located at the exact center of the data. *Mean < median < mode* - This order is typical for a dataset with a **negative skew**, where the tail is on the left due to a few **unusually small values**. - In a negatively skewed distribution, the mean is pulled to the left (lower value) by the small values, making it less than the median and mode. *Mean > median = mode* - This configuration is generally not characteristic of standard skewed distributions and would imply a specific, less common bimodal or complex distribution shape where the mode coincides with the median, but the mean is pulled higher. - While theoretically possible, it doesn't describe a typical positively skewed distribution where the mode is usually the lowest of the three. *Mean < median = mode* - This relationship would suggest a negatively skewed distribution where the median and mode are equal, but the mean is pulled to the left (lower value) by a leftward tail. - Again, this is a less typical representation of a standard negatively skewed distribution, which often follows the Mean < Median < Mode pattern.

Question 6: You submit a paper to a prestigious journal about the effects of coffee consumption on mesothelioma risk. The first reviewer lauds your clinical and scientific acumen, but expresses concern that your study does not have adequate statistical power. Statistical power refers to which of the following?

A. The probability of detecting an association when no association exists.
B. The probability of not detecting an association when an association does exist.
C. The probability of detecting an association when an association does exist. (Correct Answer)
D. The first derivative of work.
E. The square root of the variance.

Explanation: ***The probability of detecting an association when an association does exist.*** - **Statistical power** is defined as the probability that a study will correctly reject a false null hypothesis, meaning it will detect a true effect or association if one exists. - A study with **adequate statistical power** is less likely to miss a real effect. *The probability of detecting an association when no association exists.* - This describes a **Type I error** or **false positive**, often represented by **alpha (α)**. - It is the probability of incorrectly concluding an effect or association exists when, in reality, there is none. *The probability of not detecting an association when an association does exist.* - This refers to a **Type II error** or **false negative**, represented by **beta (β)**. - **Statistical power** is calculated as **1 - β**, so this option describes the complement of power. *The first derivative of work.* - The first derivative of work with respect to time represents **power** in physics, which is the rate at which work is done. - This option is a **distractor** from physics and is unrelated to statistical power in research. *The square root of the variance.* - The **square root of the variance** is the **standard deviation**, a measure of the dispersion or spread of data. - This is a statistical concept but is not the definition of statistical power.

Question 7: You are currently employed as a clinical researcher working on clinical trials of a new drug to be used for the treatment of Parkinson's disease. Currently, you have already determined the safe clinical dose of the drug in a healthy patient. You are in the phase of drug development where the drug is studied in patients with the target disease to determine its efficacy. Which of the following phases is this new drug currently in?

A. Phase 4
B. Phase 1
C. Phase 2 (Correct Answer)
D. Phase 0
E. Phase 3

Explanation: ***Phase 2*** - **Phase 2 trials** involve studying the drug in patients with the target disease to assess its **efficacy** and further evaluate safety, typically involving a few hundred patients. - The question describes a stage after safe dosing in healthy patients (Phase 1) and before large-scale efficacy confirmation (Phase 3), focusing on efficacy in the target population. *Phase 4* - **Phase 4 trials** occur **after a drug has been approved** and marketed, monitoring long-term effects, optimal use, and rare side effects in a diverse patient population. - This phase is conducted post-market approval, whereas the question describes a drug still in development prior to approval. *Phase 1* - **Phase 1 trials** primarily focus on determining the **safety and dosage** of a new drug in a **small group of healthy volunteers** (or sometimes patients with advanced disease if the drug is highly toxic). - The question states that the safe clinical dose in a healthy patient has already been determined, indicating that Phase 1 has been completed. *Phase 0* - **Phase 0 trials** are exploratory, very early-stage studies designed to confirm that the drug reaches the target and acts as intended, typically involving a very small number of doses and participants. - These trials are conducted much earlier in the development process, preceding the determination of safe clinical doses and large-scale efficacy studies. *Phase 3* - **Phase 3 trials** are large-scale studies involving hundreds to thousands of patients to confirm **efficacy**, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug to be used safely. - While Phase 3 does assess efficacy, it follows Phase 2 and is typically conducted on a much larger scale before submitting for regulatory approval.

Question 8: You are conducting a lab experiment on skeletal muscle tissue to examine force in different settings. The skeletal muscle tissue is hanging down from a hook. The experiment has 3 different phases. In the first phase, you compress the muscle tissue upwards, making it shorter. In the second phase, you attach a weight of 2.3 kg (5 lb) to its lower vertical end. In the third phase, you do not manipulate the muscle length at all. At the end of the study, you see that the tension is higher in the second phase than in the first one. What is the mechanism underlying this result?

A. The tension in phase 1 is only active, while in phase 2 it is both active and passive.
B. Shortening the muscle in phase 1 pulls the actin and myosin filaments apart.
C. Lengthening of the muscle in phase 2 increases passive tension. (Correct Answer)
D. There are more actin-myosin cross-bridges attached in phase 2 than in phase 1.
E. Shortening of the muscle in phase 1 uses up ATP stores.

Explanation: ***Lengthening of the muscle in phase 2 increases passive tension.*** - Attaching a weight of 2.3 kg (5 lb) in phase 2 **stretches** the muscle, increasing the **passive tension** generated by elastic components like **titin**. - This added passive tension, combined with any active tension, results in a **higher total tension** compared to the shortened state in phase 1 where passive tension is minimal. *The tension in phase 1 is only active, while in phase 2 it is both active and passive.* - While passive tension is more significant in phase 2 due to stretching, the muscle in phase 1, even when compressed, can still generate some **active tension** if stimulated. - The key difference contributing to higher tension in phase 2 is the additional **passive component** from stretching, not necessarily the exclusive presence of active tension in one phase. *Shortening the muscle in phase 1 pulls the actin and myosin filaments apart.* - Shortening the muscle too much, beyond its optimal resting length, leads to **overlap of actin filaments** and **crumpling of myosin filaments**, reducing the number of available cross-bridge binding sites. - This **decreases active tension** rather than pulling filaments apart, which would require excessive stretching. *There are more actin-myofibril cross-bridges attached in phase 2 than in phase 1.* - Shortening the muscle in phase 1 beyond optimal length **reduces the number of cross-bridges** that can form due to actin filament overlap. - While lengthening in phase 2 might bring the muscle closer to an **optimal length** for cross-bridge formation (increasing active tension), the primary reason for the higher tension in phase 2 as described is the increase in **passive tension** from stretching, rather than solely increased active cross-bridge formation. *Shortening of the muscle in phase 1 uses up ATP stores.* - Muscle contraction, whether shortening or lengthening, requires **ATP hydrolysis** for cross-bridge cycling. - The act of shortening itself doesn't uniquely "use up" ATP stores more significantly than other contractile actions to explain the observed tension difference; ATP is continuously consumed and regenerated during muscle activity.

Question 9: A statistician wants to study the effects of a medicine in three groups-humans, animals, and plants. He then selects randomly from these three groups. Which type of sampling is being performed?

A. Simple random sampling
B. Systematic sampling
C. Stratified random sampling (Correct Answer)
D. Cluster sampling
E. Convenience sampling

Explanation: ***Stratified random sampling*** - This method involves dividing the population into **distinct subgroups (strata)** based on shared characteristics (in this case, humans, animals, and plants), and then performing a simple random sample within each stratum. - This ensures that all subgroups are proportionally represented in the sample, which is appropriate when studying effects across different biological categories. *Simple random sampling* - This method involves selecting individuals from the entire population **purely by chance**, without first dividing them into subgroups. - It would not guarantee representation from all three distinct groups (humans, animals, and plants), which is essential for studying differential effects. *Systematic sampling* - This involves selecting samples at **regular intervals** from an ordered list or sequence. - This method is not suitable here because the population is divided into distinct, non-ordered groups rather than a continuous sequence. *Cluster sampling* - This method involves dividing the population into **clusters**, then randomly selecting some clusters and sampling all individuals within those selected clusters. - In this scenario, the initial groups (humans, animals, plants) are strata, not clusters, as the intent is to sample from within each group, not to treat the groups themselves as primary sampling units. *Convenience sampling* - This is a **non-probability sampling method** where subjects are selected based on ease of access rather than random selection. - The question explicitly states that random selection is performed from each group, ruling out convenience sampling.

Question 10: A study was undertaken to establish the relationship between the consumption of a vegetarian or non-vegetarian diet and the presence of diseases. Which statistical test should be used?

A. Chi-square test (Correct Answer)
B. T-test
C. ANOVA
D. Fisher's exact test
E. Mann-Whitney U test

Explanation: ***Chi-square test*** - The **chi-square test** is appropriate when analyzing the relationship between two **categorical variables**. In this scenario, "diet type" (vegetarian/non-vegetarian) and "presence of disease" (yes/no) are both categorical variables. - This test determines if there is a statistically significant association between the frequency counts of these two variables in a contingency table. *T-test* - A **t-test** is used to compare the **means** of two groups, typically when the dependent variable is continuous. - This test is unsuitable here because the presence of disease and diet type are categorical, not continuous, variables. *ANOVA* - **ANOVA** (Analysis of Variance) is used to compare the **means** of three or more groups, often with a continuous dependent variable. - Similar to the t-test, ANOVA is not applicable as the study involves categorical variables, not the comparison of means across multiple groups. *Fisher's exact test* - **Fisher's exact test** is similar to the chi-square test but specifically used for **small sample sizes** where the expected frequencies in any cell of the contingency table are less than 5. - While it analyzes categorical data, the chi-square test is the more general and commonly preferred test for larger sample sizes, which is generally assumed unless otherwise specified. *Mann-Whitney U test* - The **Mann-Whitney U test** is a non-parametric test used to compare differences between two independent groups when the dependent variable is **ordinal or continuous** but not normally distributed. - This test is not appropriate for analyzing the association between two categorical variables, as it requires at least one variable to have ranked or continuous data.

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free